Biotricity (NASDAQ:BTCY) & SANUWAVE Health (OTCMKTS:SNWV) Head to Head Survey

Valuation & Earnings

This table compares Biotricity and SANUWAVE Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06 million	0.69	-$14.09 million	($0.17)	-1.74
SANUWAVE Health	$41.28 million	5.63	-$25.81 million	($1.30)	-20.83

Biotricity has higher earnings, but lower revenue than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Biotricity and SANUWAVE Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
SANUWAVE Health	-1.33%	-23.83%	-20.60%

Insider and Institutional Ownership

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 42.5% of SANUWAVE Health shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Comparatively, 14.9% of SANUWAVE Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Biotricity has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, SANUWAVE Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Summary

SANUWAVE Health beats Biotricity on 7 of the 11 factors compared between the two stocks.

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.